California Product Liability Wrongful Death Lawyer: Vehicle Defects, Pharmaceutical Deaths, and Federal Preemption Analysis

HOME › CALIFORNIA PERSONAL INJURY › WRONGFUL DEATH › PRODUCT LIABILITY FATALITIES

Last updated: April 2026 — Reflects California Code of Civil Procedure §§ 335.1, 366.1, 377.30 and 377.60, Civil Code § 3294, the controlling Greenman v. Yuba Power Products (1963), Barker v. Lull Engineering (1978), and Soule v. General Motors (1994) line of California strict product liability authority, federal preemption doctrine under Riegel v. Medtronic (2008), Pliva v. Mensing (2011), and Wyeth v. Levine (2009), and the AB 35 MICRA schedule effective as of January 1, 2026

Product liability wrongful death cases are among the most legally complex and financially significant categories in California personal injury practice.

The cases combine California's plaintiff-friendly strict product liability framework — established in Greenman v. Yuba Power Products (1963) and refined over six decades — with technical evidentiary requirements, multi-defendant manufacturer-distributor-retailer chains, federal preemption defenses that can entirely bar state law claims in specific contexts, and insurance coverage architectures that frequently reach hundreds of millions of dollars in aggregate exposure.

The result is a category where case selection, theory development, and procedural discipline are exceptionally consequential.

The economic stakes are substantial. Manufacturers facing fatal product liability exposure typically carry primary product liability coverage in the $10 million to $50 million range, with excess and umbrella layers reaching $500 million or more for major manufacturers. Pharmaceutical and medical device companies maintain even larger coverage architectures because of the volume of potential claims.

Class action and mass tort consolidation through California's Judicial Council Coordinated Proceedings (JCCP) and federal multi-district litigation (MDL) processes pool similar cases for efficiency, but individual wrongful death cases proceeding outside those frameworks frequently produce the largest individual recoveries.

For the broader wrongful death framework, see our California Wrongful Death guide. For the underlying product liability framework, see our California Product Liability and Abuse guide.

California's Three Strict Product Liability Theories

California recognizes three distinct theories of strict product liability, each requiring different proof and applicable in different fact patterns.

A manufacturing defect under Greenman applies when the specific product that caused the death differed from the manufacturer's intended design — defective in its individual production rather than in the design itself.

The plaintiff must prove the product was defective when it left the manufacturer's control and that the defect caused the death. Proof typically involves engineering analysis, materials testing, and comparison with the intended product specifications.

Design defect under Barker v. Lull Engineering (1978) 20 Cal.3d 413 applies when the entire product line is defective in design. California uses a dual-test framework:

The consumer expectation test asks whether the product failed to perform as safely as an ordinary consumer would expect when used in an intended or reasonably foreseeable manner. This test applies when the product's design is within the common experience of ordinary consumers. Soule v. General Motors (1994) 8 Cal.4th 548 limited the consumer expectation test to cases where the product's failure is within ordinary consumer experience, requiring complex technical products to proceed under the risk-benefit test.

The risk-benefit test asks whether the risks of the design outweigh its benefits, considering the gravity of the potential harm, the likelihood of the harm, the feasibility of safer alternative designs, the cost of safer alternatives, and the consequences of the alternatives. Under Barker, once the plaintiff establishes prima facie evidence of causation, the burden shifts to the defendant to prove the benefits outweigh the risks.

A warning defect arises when the product was unreasonably dangerous because the manufacturer failed to provide adequate warnings of known or knowable risks. The duty to warn extends to risks known or scientifically knowable at the time of distribution. Inadequate warning theories are particularly important in cases involving pharmaceuticals, medical devices, and industrial chemicals.

Vehicle Defect Wrongful Death Cases

Defective vehicle fatalities are the largest single source of California product liability wrongful death practice. Common fact patterns include:

Rollover crashes. SUVs, trucks, and vans with high centers of gravity and design characteristics that increase rollover propensity have produced extensive California litigation.

Roof crush failures during rollovers, inadequate roof strength, and electronic stability control deficiencies all support design defect theories. Federal Motor Vehicle Safety Standards (FMVSS) 216 and 226 set baseline requirements, but California strict product liability extends beyond minimum federal standards.

Fuel system fires. Fuel tank placement, fuel line routing, fuel pump design, and post-collision fuel containment all produce documented fire risks. The Ford Pinto litigation of the 1970s and 1980s established the framework; modern fuel system defect cases continue to involve various vehicle models.

Lithium-ion battery fires in electric and hybrid vehicles present a newer fire risk pattern with distinct technical analysis. See our California Burn Injury guide for the broader vehicle fire litigation framework.

Defective airbags. The Takata airbag defect — propellant degradation producing shrapnel deployments that killed and severely injured numerous victims — produced one of the largest consumer product safety recalls in U.S. history and extensive California wrongful death litigation.

Other airbag defects include inadvertent deployment, failure to deploy in collision conditions, and inadequate restraint coverage.

Defective tires and brakes. Tire tread separation, brake system failures, and ABS deficiencies can produce fatal crashes. These cases frequently involve component manufacturer defendants in addition to the vehicle manufacturer.

Crashworthiness and restraint failures. Vehicles with inadequate occupant protection — defective seatbelts, defective seat structures, inadequate side impact protection, defective door latches that opened during crashes — support crashworthiness claims that typically apply when an underlying crash caused injury but the vehicle's defects increased the severity to fatal.

Autonomous vehicle and driver-assist defects. The growing deployment of automated driving systems, lane-keeping assistance, automatic emergency braking, and full self-driving features has produced a new generation of product liability theories.

Cases involving Tesla, Waymo, and other automated vehicle systems are appearing with increasing frequency in California courts.

For the broader motor vehicle framework, see our California Motor Vehicle guide.

Pharmaceutical Wrongful Death Cases

Pharmaceutical fatalities span a wide range of product types and require navigation of the complex federal preemption doctrine.

Brand-name drug overdose and adverse reactions. Cases involving prescription medications that caused fatal reactions, drug interactions, or overdose.

The duty to warn under California law requires manufacturers to provide adequate warnings of known and knowable risks. Wyeth v. Levine (2009) 555 U.S. 555 held that brand-name pharmaceutical manufacturers can typically face state law failure-to-warn claims because they retain the ability to strengthen warnings unilaterally under FDA Changes Being Effected procedures.

Generic drug deaths and Mensing preemption. Pliva v. Mensing (2011) 564 U.S. 604 substantially limited state law failure-to-warn claims against generic drug manufacturers.

Generic manufacturers must use the same warning as the brand-name drug under FDA regulations and cannot unilaterally strengthen warnings, creating impossibility preemption that bars most state-law warning-defect claims against generic manufacturers. The doctrine has substantial implications for pharmaceutical wrongful death cases involving generic drugs.

Opioid-related fatalities. Litigation against opioid manufacturers, distributors, and retail pharmacies for fatal overdoses has produced substantial California recoveries through the JCCP coordinated proceedings and individual case trials. The cases typically combine product liability theories with public nuisance and consumer protection claims.

Vaccine-related fatalities. The federal Vaccine Injury Compensation Program under 42 U.S.C. § 300aa-10 et seq. provides an administrative remedy for vaccine-related injuries and deaths, with state law claims preempted in most circumstances. The administrative process has its own procedural requirements and damages framework distinct from California civil litigation.

Compounded medication deaths. Pharmacy compounding errors causing fatal medication errors fall outside FDA approval frameworks and are subject to state law, product liability, and pharmacy malpractice theories.

Medical Device Wrongful Death and Riegel Preemption

Medical device wrongful death cases are governed by a complex federal preemption framework that frequently determines whether the case can proceed at all.

Class III PMA-approved devices and Riegel preemption. Riegel v. Medtronic (2008) 552 U.S. 312 held that the federal Medical Device Amendments expressly preempt state law claims that would impose requirements different from or in addition to federal Pre-Market Approval (PMA) requirements for Class III medical devices.

The doctrine substantially limits state-law product-liability claims against PMA-approved devices, though state-law claims that parallel federal requirements (rather than imposing additional ones) survive.

Common Class III device categories include implantable cardiac devices (defibrillators, pacemakers), implantable orthopedic devices, certain vascular implants, and high-risk diagnostic equipment.

Class II 510(k)-cleared devices. Devices cleared through the 510(k) substantial equivalence pathway face less robust preemption. Most California medical device fatality cases involving 510(k) products can proceed under state law product liability theories.

Common medical device fatality patterns. Defective hip implants (metal-on-metal corrosion fatalities), defective vaginal mesh (causing fatal complications in some cases), defective IVC filters (causing fatal embolism), defective knee replacements, and defective cardiac devices have all produced California wrongful death litigation. Many of these cases proceed through MDL or JCCP coordinated proceedings.

Off-label use complications. Medical devices used for purposes other than the FDA-approved indications can produce fatalities that proceed under different theories than approved-use cases, with reduced preemption defenses in some circumstances.

Consumer Product Wrongful Death

Beyond vehicles, pharmaceuticals, and medical devices, California sees substantial product liability wrongful death litigation involving consumer products.

Children's products. Defective car seats, cribs, and high chairs, as well as choking hazards in toys and defective recreational equipment, have led to extensive California litigation. The Consumer Product Safety Commission's regulatory framework provides minimum standards, but California product liability extends beyond CPSC requirements.

Firearms and weapons. Federal preemption under the Protection of Lawful Commerce in Arms Act (PLCAA) substantially limits firearms manufacturer liability, though California has enacted exceptions and California Civil Code § 3273.50 et seq. (the Firearm Industry Responsibility Act) creates additional state law theories. Firearms wrongful death litigation continues to evolve in California courts.

Recreational equipment defects. Bicycles, all-terrain vehicles, watercraft, and other recreational products causing fatal injuries support standard product liability claims.

Household products. Defective appliances causing fires or electrocution, defective furniture causing tip-over fatalities, and defective tools causing fatal injuries proceed under standard California product liability framework.

Industrial products causing non-worker fatalities. Industrial products that cause fatal injuries to non-workers (passersby, family members) support full California product liability claims unconstrained by workers' compensation exclusivity. For industrial product-related worker fatalities, see our California Workplace Fatality guide.

Identifying the Right Defendants

Product liability wrongful death cases typically proceed against multiple defendants in the manufacturing and distribution chain.

Manufacturer. The original product manufacturer is the primary defendant. Identification requires understanding the product's actual manufacturer rather than the brand name — many brands distribute products manufactured by other entities or by the brand under license.

Component manufacturers. When a specific component caused or contributed to the failure, the component manufacturer is also liable. Vehicle cases typically involve component manufacturers (tire, airbag, restraint system, electronic system manufacturers) in addition to the vehicle assembler.

Distributors and retailers. California strict product liability extends down the chain to distributors and retailers under Vandermark v. Ford Motor Co. (1964) 61 Cal.2d 256. Although distributors and retailers can seek indemnity from manufacturers, they remain directly liable to plaintiffs.

Successor entities. When the original manufacturer no longer exists, California's successor liability doctrine under Ray v. Alad Corp. (1977) 19 Cal.3d 22 can extend liability to acquiring entities that continued the original manufacturer's product line. The doctrine is particularly important for older industrial products and vehicles.

Foreign manufacturers and California jurisdiction. Products manufactured outside the United States raise distinctive jurisdictional issues. California's long-arm jurisdiction reaches foreign manufacturers under specific circumstances, but service of process and discovery against foreign defendants present practical challenges that affect case strategy.

CCP § 377.60 Beneficiaries

Wrongful death standing follows the standard California hierarchy under Code of Civil Procedure § 377.60 — surviving spouse or domestic partner, children (biological, adopted, and in some cases stepchildren and equitably adopted children), issue of deceased children, then statutory heirs under Probate Code intestacy rules, plus financial dependents demonstrating actual dependency at the time of death.

Product liability wrongful death cases frequently produce distinct beneficiary patterns by product type. Vehicle defect fatalities typically involve adult or family decedents with spouse and children beneficiaries.

Pharmaceutical and medical device fatalities frequently involve elderly decedents with adult children beneficiaries, requiring careful analysis of dependency claims. Consumer product fatalities involving children's products produce parental wrongful death claims with substantial non-economic damages.

Statute of Limitations

Wrongful death civil claim: Two years from the date of death under CCP § 335.1.

Survival action: The longer of two years from the date of death or six months after death if the personal injury limitations period had not expired at death, under CCP § 366.1.

Discovery rule for delayed-onset fatalities. California's discovery rule extends limitations in product liability cases where the connection between the product and the death was not reasonably discoverable within the standard period.

Pharmaceutical and medical device cases involving long-developing complications particularly benefit from the discovery rule application.

Federal preemption considerations. Some federal preemption defenses (particularly for medical devices and vaccines) involve their own limitation frameworks separate from California state law deadlines.

Government entity claims: Six-month administrative notice under the Government Claims Act when a government-procured or government-distributed product is involved.

Damages Framework

The damages framework follows California's broad wrongful death and survival action structure.

Wrongful death damages under CCP § 377.61 include economic losses (lost financial support, lost services, funeral and burial expenses) and non-economic losses (loss of love, companionship, comfort, affection, society, moral support, training, and guidance).

California imposes no cap on product liability wrongful death damages in ordinary cases.

Survival action damages Survival action damages under Code of Civil Procedure § 377.30 belong to the decedent's estate and include the decedent's own losses from injury through death.

Under CCP § 377.34(b), enacted by SB 447 in 2021, survival actions filed between January 1, 2022 and December 31, 2025 could recover the decedent's pre-death pain, suffering, and disfigurement.

SB 447 expired without legislative extension on January 1, 2026, and survival actions filed on or after that date have reverted to the traditional rule under CCP § 377.34(a) — only economic damages (medical expenses, lost earnings, property losses) and punitive damages are recoverable; pain, suffering, and disfigurement are not. The expiration is determined by filing date, not date of injury or death.

A narrow exception preserves pre-death pain and suffering recovery in elder abuse cases under Welfare and Institutions Code § 15657 when the plaintiff proves abuse by clear and convincing evidence.

Punitive damages under Civil Code § 3294 are particularly important in product liability wrongful death cases. Manufacturers who concealed known defects, who suppressed adverse event reporting, who continued selling products with documented fatal risks, or who failed to issue timely recalls face substantial punitive exposure.

Documentary discovery of internal manufacturer communications, FDA adverse event reports, and prior similar incident files typically establishes the malice, oppression, or fraud required for punitive damages.

Punitive damages in product liability wrongful death cases routinely reach the same magnitude as compensatory damages or higher.

Insurance and Settlement Architecture

Product liability insurance coverage is substantially larger than coverage in most other personal injury contexts.

Manufacturer product liability coverage typically ranges from $10 million primary to $500 million or more in aggregate excess and umbrella coverage for major manufacturers. Vehicle manufacturers, pharmaceutical companies, and medical device manufacturers maintain particularly substantial coverage architectures.

Component manufacturer coverage. Suppliers carry their own product liability coverage typically in the $5 million to $50 million range.

Distributor and retailer coverage. Vendor liability coverage typically extends from the manufacturer to downstream parties through additional insured endorsements and indemnification provisions.

Mass tort consolidation effects. JCCP and MDL coordinated proceedings affect insurance settlement dynamics by creating aggregate exposure that drives manufacturer settlement decisions. Individual cases proceeding outside coordinated proceedings can produce substantially larger individual recoveries but require independent insurance analysis.

Punitive damage coverage limitations. California Insurance Code § 533 generally prohibits insurance coverage of punitive damages, requiring punitive recoveries to be collected from manufacturer assets directly. Major manufacturers typically have substantial assets to satisfy punitive judgments.

What to Do After a Suspected Product Liability Wrongful Death

Preserve the product immediately. The specific product that caused the death must be retained in its post-incident condition. Vehicles should not be repaired, scrapped, or salvaged. Medical devices should be retained after explant. Consumer products should be photographed and physically preserved. Preservation letters within days are essential.

Document the chain of distribution. Receipts, prescription records, medical device implant records, vehicle title and history records, and any documentation of how the decedent came to use the product establish the manufacturer-distributor-retailer chain.

Obtain regulatory records promptly. NHTSA recall notices, complaint files, and TREAD Act submissions for vehicles. FDA Adverse Event Reporting System (FAERS) data for drugs and devices. CPSC complaint and recall data for consumer products. These records frequently establish manufacturer knowledge of fatal risks.

Identify all potentially responsible parties. Manufacturer, component manufacturers, distributors, retailers, and successor entities. Corporate research through Secretary of State filings, SEC disclosures, and trade publications establishes the proper defendants.

Coordinate with mass tort and MDL counsel. If a coordinated proceeding exists for the product type, evaluation of whether the case fits the MDL/JCCP framework versus an individual filing is a strategic decision affecting both timing and recovery.

Engage technical experts early. Engineering experts in the relevant product type, accident reconstruction experts, and medical experts establish the causation case. Specialized experts are frequently essential — automotive engineers for vehicle defect cases, biomedical engineers for medical device cases, pharmacologists for pharmaceutical cases.

Document the decedent's pre-death suffering. SB 447 survival action damages require evidence of conscious suffering. Hospital records, paramedic reports, witness accounts, and medical literature on the typical course of death from the product type all establish this claim.

Document the survivor relationships. Photographs, videos, social media records, and witness testimony from family and friends establish the wrongful death non-economic damages case.

Avoid recorded statements to manufacturer or insurer representatives without counsel. Defense representatives seek early statements that can undermine damages and liability claims. Coordinate all communications through counsel.

Retain counsel experienced in product liability wrongful death. The combination of strict liability theory selection, federal preemption analysis, multi-defendant manufacturer chain coordination, mass tort assessment, and substantial insurance navigation requires specialized expertise. For the broader product liability framework that includes abuse and elder care claims, see our California Product Liability and Abuse guide.

Frequently Asked Questions

What does the family need to prove in a California product liability wrongful death case? Under strict product liability established in Greenman v. Yuba Power Products (1963), the plaintiff must prove the product was defective (manufacturing defect, design defect, or warning defect), the defect existed when the product left the defendant's control, and the defect caused the death. Negligence is not required — strict liability focuses on the product's defective condition rather than the manufacturer's conduct.

Can the family sue if a defective vehicle caused the fatal crash? Yes, when a vehicle defect caused or contributed to the death. Defective fuel systems producing post-crash fires, defective airbags (including Takata defects), rollover defects, defective tires and brakes, defective restraint systems, and inadequate crashworthiness all support product liability wrongful death claims against vehicle manufacturers and component suppliers under the California strict liability doctrine.

What is federal preemption and how does it affect pharmaceutical wrongful death cases? Federal preemption can entirely bar state-law product liability claims in certain circumstances. Pliva v. Mensing (2011) bars most state law failure-to-warn claims against generic drug manufacturers. Riegel v. Medtronic (2008) substantially limits state law claims against PMA-approved Class III medical devices. Wyeth v. Levine (2009) preserved most state law claims against brand-name pharmaceutical manufacturers. Preemption analysis is case-specific and determines whether the claim can proceed at all.

Can the family recover the decedent's pre-death pain and suffering? It depends on when the survival action was filed. Cases filed between January 1, 2022 and December 31, 2025 retain pre-death pain and suffering recovery under SB 447's amendment to CCP § 377.34. Cases filed on or after January 1, 2026 have reverted to the traditional rule — only economic damages and punitive damages are recoverable in survival actions; pain, suffering, and disfigurement are not. Elder abuse cases under W&I § 15657 retain pre-death pain and suffering recovery as a separate statutory exception.

Are punitive damages available in California product liability wrongful death cases? Yes, and they are particularly important in this category. Manufacturers who concealed known defects, suppressed adverse event reports, continued selling products with documented fatal risks, or failed to issue timely recalls face substantial punitive exposure under Civil Code § 3294. Punitive damages in product liability wrongful death cases routinely reach the same magnitude as compensatory damages or higher.

Should I join a class action or proceed with an individual case? Mass tort consolidation through California's JCCP and federal MDL processes pools similar cases for efficiency, but individual wrongful death cases proceeding outside those frameworks frequently produce the largest individual recoveries. The strategic decision depends on the strength of the individual case, the consolidated proceeding's settlement structure, and the family's specific damages profile. Both pathways have specific procedural requirements and timing implications.

How long does the family have to file a California product liability wrongful death claim? Two years from the date of death under CCP § 335.1. California's discovery rule may extend limitations when the connection between the product and the death was not reasonably discoverable within the standard period — particularly relevant in pharmaceutical and medical device cases involving long-developing complications.

DISCLOSURE 

This page is published and maintained by 1000Attorneys.com, a California State Bar Certified Lawyer Referral and Information Service, LRIS Certificate No. 0128, accredited by the American Bar Association and established in 2005. The information on this page is for general educational purposes only and is not legal advice. 1000Attorneys.com is not a law firm and does not provide legal representation. For legal advice about your specific situation, consult a qualified California attorney licensed to practice in the jurisdiction where your claim arises.